ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
CPF/SRS 投资
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
港股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
MIRXES-B
45.820
-0.360
-0.78%
手动刷新
成交量:
18.66万
成交额:
859.26万
市值:
126.62亿
市盈率:
-59.58
高:
47.000
开:
47.000
低:
45.020
收:
46.180
52周最高:
48.700
52周最低:
27.050
股本:
2.76亿
香港流通股本:
2.76亿
量比:
0.35
换手率:
0.07%
股息:
- -
股息率:
- -
每股收益(LYR):
-0.769
净资产收益率:
--
总资产收益率:
-51.53%
市净率:
-7.78
市盈率(LYR):
-59.58
市销率:
80.02
数据加载中...
总览
公司
新闻
公告
港股IPO赚钱效应显著!恒瑞医药一手赚2590港元
老虎资讯综合
·
05/23
新股首日 | MIRXES-B(02629)首挂上市 早盘高开24.46% 公司为新加坡生物科技公司
智通财经
·
05/23
MIRXES-B(02629)出现大手卖出45.25万股,成交价$29.0,涉资1.312千万
阿斯达克财经
·
05/23
MIRXES-B香港公开发售获25.51倍认购 全球发售净筹约8.8亿港元
新浪港股
·
05/23
港股IPO动态:今日恒瑞医药、MIRXES-B上市
格隆汇
·
05/23
新股定价|MIRXES-B一手中签率95%,认购4手稳中一手
老虎资讯综合
·
05/23
港股IPO赚钱效应太强了!2只新股暗盘暴涨
东方财富
·
05/23
《新股》MIRXES-B(02629.HK)公开发售获25.5倍认购 一手中签率95%
阿斯达克财经
·
05/22
【新股IPO】MIRXES-B(02629)每股定价23.3港元 一手中签率95%
金吾财讯
·
05/22
MIRXES-B(02629)香港公开发售获25.51倍认购 全球发售净筹约8.8亿港元
智通财经
·
05/22
MIRXES-B香港IPO发行价定为每股23.30港元 净筹8.8亿港元
格隆汇资讯
·
05/22
新股暗盘 | MIRXES-B(02629)暗盘收涨逾33% 每手赚790港元
智通财经网
·
05/22
新股暗盘 | MIRXES-B(02629)暗盘盘初上涨逾25% 每手赚600港元
智通财经
·
05/22
老虎暗盘 | MIRXES-B涨近20%,每手赚450港元
老虎资讯综合
·
05/22
【港股IPO动态:今日宁德时代上市】今日宁德时代(3750.HK)上市,派格生物医药-B(2565.HK)、吉宏股份(2603.HK)、恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。
金融界
·
05/20
一周IPO观察:宁王、恒瑞申购踊跃,绿茶破发且绿鞋用尽,手回集团过讯
财经自媒体
·
05/19
狠人孙彤宇,第二个IPO要来
正商参阅
·
05/16
觅瑞MIRXES-B冲刺港交所,孙彤宇持股成大股东
DoNews
·
05/16
【港股IPO动态:今日绿茶集团上市】今日绿茶集团(6831.HK)上市,恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。
金融界
·
05/16
生物科技公司觅瑞香港上市集资8.8亿港元 每股售价23.30港元
联合早报
·
05/15
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/02629/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02629","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","market":"HK","secType":"STK","nameCN":"MIRXES-B","latestPrice":45.82,"timestamp":1756195697322,"preClose":46.18,"halted":0,"volume":186600,"delay":0,"floatShares":276342331,"shares":276342331,"eps":-0.76899,"marketStatus":"已收盘","change":-0.36,"latestTime":"08-26 16:08:17","open":47,"high":47,"low":45.02,"amount":8592628,"amplitude":0.042876,"askPrice":45.82,"askSize":1500,"bidPrice":45.7,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.76899,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1756258200000},"marketStatusCode":5,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":46.18,"openAndCloseTimeList":[[1756171800000,1756180800000],[1756184400000,1756195200000]],"volumeRatio":0.352432,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02629\",,,,,undefined,":{"symbol":"02629","floatShares":276342331,"roa":"-51.53%","roe":"--","lyrEps":-0.76899,"volumeRatio":0.352432,"shares":276342331,"dividePrice":0,"high":47,"amplitude":0.042876,"preClose":46.18,"low":45.02,"week52Low":27.05,"pbRate":"-7.78","psRate":"80.02","week52High":48.7,"institutionHeld":0,"latestPrice":45.82,"committee":-0.764706,"eps":-0.76899,"divideRate":0,"volume":186600,"delay":0,"ttmEps":-0.76899,"open":47,"prevYearClose":23.3,"prevWeekClose":45.82,"prevMonthClose":30.55,"prevQuarterClose":34.5,"fiveDayClose":48.36,"twentyDayClose":31,"sixtyDayClose":28.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02629\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02629","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02629\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02629\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02629\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02629","date":"2025-08-25","current":-16.849413,"percent":0.015625,"low":-17.63001,"twenty":-12.493638,"median":-11.382498,"eighty":-10.789519,"high":-10.373055,"avg":-11.989697,"sd":1.72626,"marketCap":12152035222},"quantilePoints":[{"date":"2025-05-30","current":-10.615633,"twenty":-10.820807,"median":-10.729406,"eighty":-10.614136,"marketCap":7683833445},{"date":"2025-06-06","current":-10.752673,"twenty":-10.811558,"median":-10.713624,"eighty":-10.576495,"marketCap":7789091437},{"date":"2025-06-13","current":-10.566273,"twenty":-10.761884,"median":-10.608146,"eighty":-10.555773,"marketCap":7657518947},{"date":"2025-06-20","current":-12.580768,"twenty":-10.923966,"median":-10.686264,"eighty":-10.56693,"marketCap":9117973591},{"date":"2025-06-27","current":-12.5082,"twenty":-12.340962,"median":-10.752673,"eighty":-10.581112,"marketCap":9065344595},{"date":"2025-07-04","current":-11.927039,"twenty":-12.355485,"median":-10.862871,"eighty":-10.586526,"marketCap":8644312625},{"date":"2025-07-11","current":-11.200931,"twenty":-12.261215,"median":-11.092147,"eighty":-10.600008,"marketCap":8118022663},{"date":"2025-07-18","current":-11.402889,"twenty":-12.217621,"median":-11.255392,"eighty":-10.612638,"marketCap":8262752403},{"date":"2025-07-25","current":-11.182791,"twenty":-12.077376,"median":-11.219171,"eighty":-10.651065,"marketCap":8104865414},{"date":"2025-08-01","current":-11.128301,"twenty":-11.949795,"median":-11.200931,"eighty":-10.68858,"marketCap":8065393667},{"date":"2025-08-08","current":-11.930929,"twenty":-11.952128,"median":-11.246394,"eighty":-10.71678,"marketCap":8646944075},{"date":"2025-08-15","current":-16.088166,"twenty":-12.119645,"median":-11.255421,"eighty":-10.743366,"marketCap":11636271059},{"date":"2025-08-22","current":-16.714103,"twenty":-12.435432,"median":-11.355275,"eighty":-10.780307,"marketCap":12057303029},{"date":"2025-08-25","current":-16.849413,"twenty":-12.493638,"median":-11.382498,"eighty":-10.789519,"marketCap":12152035222}],"updateTime":1756186957766},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02629\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138960967","title":"港股IPO赚钱效应显著!恒瑞医药一手赚2590港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138960967","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138960967?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:27","pubTimestamp":1747963668,"startTime":"0","endTime":"0","summary":"5月23日,港股IPO赚钱效应显著!恒瑞医药高开逾29%,一手赚2590港元;MIRXES-B高开逾24%,一手赚570港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"92258637d6ff1e9cb4f4844790de8572","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","BK0188","07226","01276","BK4614","LU1064131003.USD","BK0239","BK0060","600276","LU2148510915.USD","LU0405327494.USD","LU2488822045.USD","HSTECH","BK0012","LU2328871848.SGD","LU1064130708.USD","02629","BK0028","LU0405327148.USD","YANG","LU1328615791.USD"],"gpt_icon":0},{"id":"2537714959","title":"新股首日 | MIRXES-B(02629)首挂上市 早盘高开24.46% 公司为新加坡生物科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2537714959","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537714959?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:25","pubTimestamp":1747963506,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,MIRXES-B首挂上市,公告显示,每股定价23.3港元,共发行4662万股股份,每手100股,所得款项净额约8.81亿港元。截至发稿,涨24.46%,报29港元,成交额9027.65万港元。公开资料显示,Mirxes成立于2014年,公司是一家总部位于新加坡的微小核糖核酸技术公司,致力于使疾病筛查诊断解决方案在亚洲关键市场触手可及。据悉,集团的核心产品GASTROClearTM为一个由12种miRNA生物标志物组成的用于胃癌筛查的基于血液的miRNA检测组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1296695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159837","02629"],"gpt_icon":1},{"id":"2537974808","title":"MIRXES-B(02629)出现大手卖出45.25万股,成交价$29.0,涉资1.312千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2537974808","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537974808?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 09:20","pubTimestamp":1747963200,"startTime":"0","endTime":"0","summary":"[大手成交]MIRXES-B(02629)在上午09:20出现大手卖出,成交量为45.25万,成交价为港币$29.0,涉资1.312千万。至目前为止,股价无升跌,今日最高价为$30.7,而最低价为$24.0,总成交量为307.37万股,总成交金额港币$9.028千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180815142908460_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT25052318/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02629"],"gpt_icon":0},{"id":"2537975760","title":"MIRXES-B香港公开发售获25.51倍认购 全球发售净筹约8.8亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537975760","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537975760?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 08:12","pubTimestamp":1747959120,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n MIRXES-B(02629)公布配发结果,公司全球发售4662万股股份,香港公开发售占12.60%,国际发售占87.40%。每股发售价23.3港元,全球发售净筹约8.8亿港元。每手100股,预期股份将于 2025 年 5 月 23 日(星期五)上午九时正开始在联交所买卖。\n 其中,香港公开发售获25.51 倍认购,国际发售获0.98倍认购。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggipo/2025-05-23/doc-inexnynn9034272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02629"],"gpt_icon":0},{"id":"2537514978","title":"港股IPO动态:今日恒瑞医药、MIRXES-B上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2537514978","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537514978?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 06:10","pubTimestamp":1747951802,"startTime":"0","endTime":"0","summary":"格隆汇5月23日|今日恒瑞医药(1276.HK)、MIRXES-B(2629.HK)上市,手回集团(2621.HK)处于申购期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052306100794ff9250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052306100794ff9250&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSCEI","HSTECH","02629","01276"],"gpt_icon":0},{"id":"1174495391","title":"新股定价|MIRXES-B一手中签率95%,认购4手稳中一手","url":"https://stock-news.laohu8.com/highlight/detail?id=1174495391","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174495391?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 05:47","pubTimestamp":1747950464,"startTime":"0","endTime":"0","summary":"5月23日,$MIRXES-B$公布配发结果,公司全球发售4662万股股份,香港公开发售占12.6%,国际发售占87.4%,其中,香港公开发售获25.51倍认购,国际发售获0.98倍认购。每股发售价23.3港元,全球发售净筹约8.8亿港元。集团成立于2014年,是一家总部位于新加坡的微小核糖核酸技术公司,致力于使疾病筛查诊断解决方案在亚洲关键市场触手可及。集团的核心产品GASTROClearTM为一个由12种miRNA生物标志物组成的用于胃癌筛查的基于血液的miRNA检测组。","market":"hk","thumbnail":"https://static.tigerbbs.com/26d35a88c8d9d9d46abd395d2bd24396","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/26d35a88c8d9d9d46abd395d2bd24396"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股定价|MIRXES-B一手中签率95%,认购4手稳中一手","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":1},{"id":"2537201629","title":"港股IPO赚钱效应太强了!2只新股暗盘暴涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2537201629","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537201629?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 05:25","pubTimestamp":1747949147,"startTime":"0","endTime":"0","summary":"近期,港股IPO的赚钱效应太强了!5月22日晚间,即将在23日登陆港股市场的两只新股——恒瑞医药和MIRXES-B在暗盘竞价期间都出现暴涨。数据显示,恒瑞医药暗盘涨幅达32.24%,MIRXES-B涨幅达到34.76%。创新药销售收入占总收入的百分比由2022年的38.1%增至2023年的43.4%,并进一步增至2024年的46.3%。而在今年已上市的23家港股公司中,仅有6家公司首日出现破发,其余公司悉数上涨。其中,映恩生物涨幅超过116%,蜜雪集团的涨幅也超过43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052305260194ff8b28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052305260194ff8b28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01276","HSCEI","02629","HSTECH"],"gpt_icon":1},{"id":"2537529923","title":"《新股》MIRXES-B(02629.HK)公开发售获25.5倍认购 一手中签率95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537529923","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537529923?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 23:49","pubTimestamp":1747928940,"startTime":"0","endTime":"0","summary":"MIRXES-B公布招股结果,香港公开发售接获25.51倍认购,一手中签率95%,认购四手获稳派一手。国际发售录得0.98倍认购。发售价23.3元,所得净额8.81亿元。股份预期周五挂牌。总部位于新加坡的微小核糖核酸技术公司MIRXES-B是次拟全球发售4,662万股,公开发售占10%。基石投资者北京浔瑞企业管理合伙企业及复星国际旗下Evergreen Gate分别认购5,000万美元及792万美元等值股份。(港股报价延迟最少十五分钟。沽空资料截至 2025-05-22 16:25。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250515083128813_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250515083128813_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1441834/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02629"],"gpt_icon":0},{"id":"2537940909","title":"【新股IPO】MIRXES-B(02629)每股定价23.3港元 一手中签率95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537940909","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537940909?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 22:55","pubTimestamp":1747925736,"startTime":"0","endTime":"0","summary":"金吾财讯 | MIRXES-B(02629)公布招股结果,每股定价23.3港元,集资10.86亿港元,净额约8.81亿港元。每手100股,一手中签率95.00%,认购4手才可稳获一手。公开发售部分认购额为25.51倍,国际发售认购额为0.98倍。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/MWIxNzM2MjE4MjI2OTA1.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MWIxNzM2MjE4MjI2OTA1.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1959152","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0},{"id":"2537994400","title":"MIRXES-B(02629)香港公开发售获25.51倍认购 全球发售净筹约8.8亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537994400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537994400?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 21:50","pubTimestamp":1747921848,"startTime":"0","endTime":"0","summary":"智通财经APP讯,MIRXES-B(02629)公布配发结果,公司全球发售4662万股股份,香港公开发售占12.60%,国际发售占87.40%。每股发售价23.3港元,全球发售净筹约8.8亿港元。每手100股,预期股份将于 2025 年 5 月 23 日(星期五)上午九时正开始在联交所买卖。其中,香港公开发售获25.51 倍认购,国际发售获0.98倍认购。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1296613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02629"],"gpt_icon":0},{"id":"2537942971","title":"MIRXES-B香港IPO发行价定为每股23.30港元 净筹8.8亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537942971","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537942971?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 21:49","pubTimestamp":1747921769,"startTime":"0","endTime":"0","summary":"格隆汇5月22日丨MIRXES-B(02629.HK)公告,公司全球发售46,620,000股股份,每股发售股份23.30港元,所得款项净额8.8亿港元。香港公开发售股份数目占全球发售股份数目12.60%,获认购25.51倍;国际发售股份数目占全球发售股份87.40%,获认购0.98倍。假设香港公开发售于2025年5月23日(星期五)上午八时正(香港时间)或前成为无条件,则预期股份将于2025年5月23日(星期五)上午九时正开始在联交所买卖。股份将以每手买卖单位100股股份进行买卖,股份的股份代号将为2629。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052221494794ff4335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052221494794ff4335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629"],"gpt_icon":0},{"id":"2537910412","title":"新股暗盘 | MIRXES-B(02629)暗盘收涨逾33% 每手赚790港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537910412","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537910412?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 18:37","pubTimestamp":1747910220,"startTime":"0","endTime":"0","summary":"MIRXES-B(02629)将于5月23日(周五)在香港挂牌。截至收盘,利弗莫尔证券暗盘交易显示报价31.2港元,较招股价23.3港元上涨33.91%,每手100股,不计手续费,每手赚790港元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-05-22/doc-inexmwyy6888915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02629"],"gpt_icon":0},{"id":"2537907209","title":"新股暗盘 | MIRXES-B(02629)暗盘盘初上涨逾25% 每手赚600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537907209","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537907209?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 16:25","pubTimestamp":1747902303,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,MIRXES-B(02629)将于5月23日(周五)在香港挂牌。截至发稿,暗盘交易显示报价29.3港元,较招股价23.3港元上涨25.75%,每手100股,不计手续费,每手赚600港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1296352.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02629"],"gpt_icon":0},{"id":"1149161325","title":"老虎暗盘 | MIRXES-B涨近20%,每手赚450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149161325","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149161325?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 16:17","pubTimestamp":1747901827,"startTime":"0","endTime":"0","summary":"本周四,新加坡RNA技术公司 $MIRXES-B$ 开启暗盘交易,截至发稿报24.3港元,涨幅8.58%,每手赚200港元:成立于2014年的觅瑞作为一家微小核糖核酸技术公司,致力于使疾病筛查诊断解决方案在亚洲关键市场触手可及。财务数据显示,2022年至2024年,觅瑞分别实现收益1775.9万美元、2418.5万美元和2028.27万美元,但同期亏损持续扩大,分别为5620.27万美元、6956.93万美元及9221.47万美元。电商行业传奇人物孙彤宇通过全资拥有的Central Road持有觅瑞22.03%股份,成为第一大股东。","market":"hk","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4ced5ebc15dd7b799c1c8ea5b39c4a94","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"老虎暗盘 | MIRXES-B涨近20%,每手赚450港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02629"],"gpt_icon":0},{"id":"2536655551","title":"【港股IPO动态:今日宁德时代上市】今日宁德时代(3750.HK)上市,派格生物医药-B(2565.HK)、吉宏股份(2603.HK)、恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2536655551","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536655551?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 06:51","pubTimestamp":1747695077,"startTime":"0","endTime":"0","summary":"今日宁德时代(3750.HK)上市,派格生物医药-B(2565.HK)、吉宏股份(2603.HK)、恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1ea80db38c3506c20a683f9ead28ae6d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/20065150517602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["EVS.SI","LU2249611893.SGD","LU0029875118.USD","HSCEI","BK0012","LU0607220059.USD","YANG","BK0224","LU2097828714.EUR","LU2289578879.USD","BK4526","161726","LU0132412106.USD","LU2506951792.HKD","LU1880383440.USD","600276","BK4519","IE00B8HQ1Z84.USD","LU0828238088.HKD","LU2399975544.HKD","LU1961090484.USD","LU2153592121.USD","LU0320764755.SGD","LU1770034418.SGD","LU2275660780.HKD","SGXZ81163826.USD","JKS","LU0456827905.SGD","03750","IE00BD6J9T35.USD","399441","LU2360107325.USD","LU0164872284.USD","LU0651947912.USD","LU1969619763.USD","LU0871576103.HKD","LU0228659784.USD","LU0516422952.EUR","02629","IE00B543WZ88.USD","HSTECH","02603","BK0188","LU1655091616.SGD","002803","LU0011963245.USD"],"gpt_icon":0},{"id":"2536960524","title":"一周IPO观察:宁王、恒瑞申购踊跃,绿茶破发且绿鞋用尽,手回集团过讯","url":"https://stock-news.laohu8.com/highlight/detail?id=2536960524","media":"财经自媒体","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536960524?lang=zh_cn&edition=fundamental","pubTime":"2025-05-19 11:27","pubTimestamp":1747625220,"startTime":"0","endTime":"0","summary":"港股IPO观察截止2025年的第20周,港交所3家新股上市,1家招股,3家通过聆讯,8家递交招股书。首日大跌12%,招银国际为稳价人,绿鞋已基本用完。本次IPO每股发售价23.30港元,计划全球发售4662万股,无超额配股权。手回集团通过IPO聆讯5月15日,小雨伞保险的母公司深圳手回集团在港交所披露聆讯后的招股书,或很快在香港主板IPO上市。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-05-19/doc-inexakse3019512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4231","LU2097828805.USD","HK0000306701.USD","01276","BK4023","LU0405327494.USD","LU0572944931.SGD","HK0000320223.HKD","DLHZ","RNBW","02603","LHAI","FMFC","LU0828237940.HKD","BK0183","600276","LU0370786039.SGD","RNA","02629","02899","LU1328615791.USD","LU0886674414.USD","LU0096374516.USD","ETOR","LU2097828714.EUR","FTRK","LU1969619763.USD","OMSE","BK0188","ADC","BK1198","LU0345780521.USD","BK1544","03750","LU1504937902.USD","ARAI","LU1720050803.USD","BK4585","LU0345780281.USD","MSGY","EGG","LU1251922891.USD","LU1064130708.USD","02565","BK4080","HSPO","LAWR"],"gpt_icon":1},{"id":"2535394662","title":"狠人孙彤宇,第二个IPO要来","url":"https://stock-news.laohu8.com/highlight/detail?id=2535394662","media":"正商参阅","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535394662?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 19:36","pubTimestamp":1747395360,"startTime":"0","endTime":"0","summary":"尽管其2024年收入0.2亿美元、净亏损0.92亿美元的财务数据仍显刺眼,但有狠人孙彤宇宇稳坐大股东之位,再加上高榕资本、华润正大等知名机构背书,累计融资1.67亿美元撑腰,以及“全球唯一获批胃癌筛查IVD产品”的技术王牌,市场热情瞬间被点燃。生物科技IPO历来是“故事驱动”。觅瑞此次IPO募资,不过勉强覆盖两年亏损额。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-05-16/doc-inewukky5994717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0918141887.USD","LU1105468828.SGD","LU1152091754.HKD","LU0979878070.USD","BK4122","LU1267930227.SGD","BK4548","LU0328353924.USD","BK4533","BK4527","ALBmain","LU2226246903.HKD","BK4505","BK4579","BK4504","LU0651946864.USD","LU0501845795.SGD","LU0128525689.USD","02629","BK4554","BK4502","LU1235294995.USD","LU0052756011.USD","BK4575","LU1688375341.USD","LU0821914370.USD","BK4531","LU1242518857.USD","LU0348816934.USD","IE00BFMHRM44.USD","LU1051769294.HKD","LU0348814723.USD","BK4565","LU1048596156.SGD","LU1152091168.USD","LU1769817179.HKD","BK4524","BK4607","BK4220","BK4558","BK4503","LU1051768304.USD","BK4526","BK4538","LU0047713382.USD","BK4534","BK4588","BK4535"],"gpt_icon":1},{"id":"2536604348","title":"觅瑞MIRXES-B冲刺港交所,孙彤宇持股成大股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2536604348","media":"DoNews","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536604348?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 09:36","pubTimestamp":1747359362,"startTime":"0","endTime":"0","summary":"觅瑞MIRXES-B自5月15日起启动招股程序,计划于5月23日在港交所挂牌上市,由中金公司与建银国际担任联席保荐人。财务数据显示,2022年至2024年,觅瑞分别实现收益1775.9万美元、2418.5万美元和2028.27万美元,但同期亏损持续扩大,分别为5620.27万美元、6956.93万美元及9221.47万美元。值得注意的是,电商行业传奇人物孙彤宇通过全资拥有的Central Road持有觅瑞22.03%股份,成为第一大股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516093922975b3b23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516093922975b3b23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02629"],"gpt_icon":0},{"id":"2535091298","title":"【港股IPO动态:今日绿茶集团上市】今日绿茶集团(6831.HK)上市,恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535091298","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535091298?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 06:15","pubTimestamp":1747347321,"startTime":"0","endTime":"0","summary":"今日绿茶集团(6831.HK)上市,恒瑞医药(1276.HK)、MIRXES-B(2629.HK)处于申购期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16061550430260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0012","01276","BK0060","LU0405327494.USD","06831","02629","LU2488822045.USD","BK0239","LU1064131003.USD","LU2328871848.SGD","HSTECH","LU1064130708.USD","BK0196","BK0028","BK0183","LU0405327148.USD","600276","BK4614","BK0188","LU1969619763.USD","LU1328615791.USD","LU2148510915.USD","HSCEI","YANG"],"gpt_icon":0},{"id":"2535890926","title":"生物科技公司觅瑞香港上市集资8.8亿港元 每股售价23.30港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535890926","media":"联合早报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535890926?lang=zh_cn&edition=fundamental","pubTime":"2025-05-15 16:41","pubTimestamp":1747298507,"startTime":"0","endTime":"0","summary":"觅瑞公司致力于使疾病筛查诊断解决方案在亚洲关键市场(包括新加坡及中国)触手可及。公司在2019年于新加坡推出的旗舰产品GastroClear,是全球首个用于早期检测胃癌的miRNA血液检测组。它还有两种其他产品已商业化,另有六种产品处于临床前阶段。中国目前是觅瑞的最大市场之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"zaobao_highlight","url":"https://www.zaobao.com/realtime/singapore/story20250515-6373097","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zaobao.com/realtime/singapore/story20250515-6373097","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zaobao_highlight","symbols":["159837","02629"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":88,"code":"91000000","status":"200"}]}}